Hubei Jumpcan Pharmaceutical Co.,Ltd.’s Net Profit Rose 32.1% in First Half of 2023

Hubei Jumpcan Pharmaceutical Co.,Ltd. (湖北济川药业股份有限公司) (600566.SH) reported a net profit of 1.3 billion yuan in the first half of 2023, up 32.1% year-on-year.

Meanwhile, the company posted 4.6 billion yuan in revenue, up 19.8% year-on-year.

At the end of the reporting period, it had 16.4 billion yuan in total assets and 4.5 billion yuan in total liabilities, with a liability-to-asset ratio of 27.4%.